Home
Finance
Companies
Industry
Market

NASDAQ:VRDN

Viridian Therapeutics Inc [VRDN] stock Resumed by Jefferies analyst, price target now $44

November 7, 2025

Caleb Clifford

Viridian Therapeutics Inc [NASDAQ: VRDN] gained 12.61% on the last trading session, reaching $27.5 price per share at the time. ...

most recent

Finance

Goldman slashes price target on Altice USA Inc [ATUS] – find out why.

Companies

Keefe Bruyette lifts Genworth Financial Inc [GNW] price estimate. Who else is bullish?

Market

Viridian Therapeutics Inc [VRDN] stock Resumed by Jefferies analyst, price target now $44

Industry

Amer Sports Inc [AS] is 58.58% higher this YTD. Is it still time to buy?

Finance

For Americold Realty Trust Inc [COLD], Analyst sees a rise to $14. What next?

Companies

Market Analysts see Amplitude Inc [AMPL] gaining to $13. Time to buy?

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled